VYNE Therapeutics (VYNE) Ownership - Who owns VYNE Therapeutics?

Profile

Industry
Pharmaceuticals Major
Address
685 Route 202/206 North
Phone
+1 800 775-7936
Employees
10
Web
https://www.vynetherapeutics.com

Details

Group
Domestic Stock Funds
Category
Biotechnology
Capitalization
30.95M
P/E Ratio
N/A
Total Cash
N/A
Projected Growth
N/A
Total Debt
180K
Revenue
423K
Risk (Beta)
2.38
Dividend Yield
N/A
Total Cash/Share
N/A
Total Debt/Equity
N/A
Revenue/Share
0.02 USD as % of share price

Fundamentals

VYNE
Capitalization
30.9M
P/E Ratio
N/A
Risk (Beta)
2.38
Dividend Yield
N/A
Total Cash
N/A
Total Cash/Share
N/A
Total Debt
180K
Total Debt/Equity
N/A
Projected Growth (PEG Ratio)
N/A
Revenue/Share (as % of the share price)
0.02%
Revenue
423K
ROE
N/A
Book Value
83.4M
P/B Ratio
0.37
Cash Flow
N/A
Earnings
-1.19
Average Daily Volume YTD
N/A
Common Shares Outstanding - Security Level
1K
Current Ratio
13.02
Current Revenue Per Employee
9800.00
Dividends Per Share - Security
N/A
EBITDA
-30.76M
Float
N/A
Float - Current
N/A
Gross Income Margin
60.60
Revenue To Assets
-45.82
Shares Held By Institutions
21.8M
Shares Outstanding - Current
14.5M
Total Liabilities
8.31M
Total Volume MTD
N/A
Value
N/A
Gain YTD
-8.584
View a ticker or compare two or three
VYNE
Daily Signal changed days ago
Gain/Loss if shorted
Show more...
Ad is loading...
A.I.Advisor
published price charts
A.I. Advisor
published General Information

General Information

a company, which engages in development and commercialization of serlopitant products

Industry Biotechnology

Profile
Fundamentals
Details
Industry
Pharmaceuticals Major
Address
685 Route 202/206 North
Phone
+1 800 775-7936
Employees
10
Web
https://www.vynetherapeutics.com